Results 241 to 250 of about 313,112 (301)
Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential. [PDF]
Karakülah YS +3 more
europepmc +1 more source
Galvanic‐Cell‐Based Self‐Powered Bioelectronic Devices
The emerging galvanic‐cell‐based self‐powered bioelectronics for biomedical applications with passive and active control strategies are summarized. In addition, the challenges and opportunities for galvanic devices are also discussed. Abstract Bioelectronic devices hold significant promise for advancing biomedical technologies, addressing critical ...
Yu Xin +4 more
wiley +1 more source
Case Report: Fever of unknown origin with hemophagocytic lymphohistiocytosis and intestinal hemorrhage-a successfully treated case of severe visceral leishmaniasis. [PDF]
Wang H, Li J, Huang W.
europepmc +1 more source
450 daily cases of infectious intestinal disease in Malta
Charmaine Gauci
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
The Role of the Intestinal Microbiome in Inflammation and Cancer. [PDF]
Zeissig S +5 more
europepmc +1 more source
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding +11 more
wiley +1 more source
This study introduces glutathione‐stabilized gold nanoparticles for targeted lithium delivery (LiG‐AuNPs), enabling the controlled modulation of Glycogen Synthase Kinase‐3 (GSK‐3β). These non‐toxic, 2‐nm particles release lithium intracellularly, effectively inhibiting GSK‐3β in the brain without significant plasma lithium alterations.
Antonio Buonerba +20 more
wiley +1 more source

